Neuroinflammatory mediators in acquired epilepsy: an update.

Autor: Chen Y; Department of Pharmaceutical Sciences, College of Pharmacy, The University of Tennessee Health Science Center, Memphis, TN, USA., Nagib MM; Department of Pharmaceutical Sciences, College of Pharmacy, The University of Tennessee Health Science Center, Memphis, TN, USA.; Department of Pharmacology and Toxicology, Faculty of Pharmacy, Misr International University, Cairo, Egypt., Yasmen N; Department of Pharmaceutical Sciences, College of Pharmacy, The University of Tennessee Health Science Center, Memphis, TN, USA., Sluter MN; Department of Pharmaceutical Sciences, College of Pharmacy, The University of Tennessee Health Science Center, Memphis, TN, USA., Littlejohn TL; Department of Pharmaceutical Sciences, College of Pharmacy, The University of Tennessee Health Science Center, Memphis, TN, USA., Yu Y; Department of Pharmaceutical Sciences, College of Pharmacy, The University of Tennessee Health Science Center, Memphis, TN, USA., Jiang J; Department of Pharmaceutical Sciences, College of Pharmacy, The University of Tennessee Health Science Center, Memphis, TN, USA. jjiang18@uthsc.edu.

Publikováno v: Inflammation research : official journal of the European Histamine Research Society ... [et al.] [Inflamm Res] 2023 Apr; Vol. 72 (4), pp. 683-701. Date of Electronic Publication: 2023 Feb 06.